|
Carlos Curbelo
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Sale
|
Oct. 10, 2017 |
$$1,001 - $15,000 |
Nov. 3, 2017 |
|
Thomas MacArthur
|
house |
VIRTUS SEIX FLOATING RATE HIGH INCOME FUND |
VSRIX |
FUND |
Purchase
|
Oct. 6, 2017 |
$$15,001 - $50,000 |
Nov. 5, 2017 |
|
James M Inhofe
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Purchase
|
Sept. 15, 2017 |
$$50,001 - $100,000 |
Sept. 19, 2017 |
|
Francis Rooney
|
house |
Brown Advisory - Novartis AG Sponsored ADR |
NVS |
STOCK |
Purchase
|
Sept. 13, 2017 |
$$1,000-$15,000 |
Sept. 18, 2017 |
|
John A. Yarmuth
|
house |
CVs Health Corporation (CVs) |
CVS |
STOCK |
Sale
|
Sept. 11, 2017 |
$$1,001 - $15,000 |
Oct. 22, 2017 |
|
Shelley M Capito
|
senate |
Las Vegas Sands Corp. |
LVS |
STOCK |
Purchase
|
Sept. 8, 2017 |
$$1,001 - $15,000 |
Oct. 6, 2017 |
|
Shelley M Capito
|
senate |
Novartis AG |
NVS |
STOCK |
Purchase
|
Sept. 5, 2017 |
$$1,001 - $15,000 |
Oct. 16, 2017 |
|
K. Michael Conaway
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Sale
|
Aug. 25, 2017 |
$$1,001 - $15,000 |
Oct. 4, 2017 |
|
K. Michael Conaway
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Sale
|
Aug. 24, 2017 |
$$1,001 - $15,000 |
Oct. 4, 2017 |
|
Gary Palmer
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Aug. 7, 2017 |
$$1,001 - $15,000 |
Sept. 29, 2018 |
|
Thomas MacArthur
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
July 28, 2017 |
$$1,001 - $15,000 |
Aug. 3, 2017 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale
|
July 28, 2017 |
$$50,001 - $100,000 |
Aug. 3, 2017 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale
|
July 28, 2017 |
$$1,001 - $15,000 |
Aug. 3, 2017 |
|
Thomas MacArthur
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
July 28, 2017 |
$$1,001 - $15,000 |
Aug. 3, 2017 |
|
John Rutherford
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
July 11, 2017 |
$$1,001 - $15,000 |
Aug. 20, 2018 |
|
Patty Murray
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Sale (Full)
|
June 15, 2017 |
$$1,001 - $15,000 |
June 22, 2017 |
|
Sheldon Whitehouse
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Sale (Partial)
|
May 30, 2017 |
$$15,001 - $50,000 |
June 8, 2017 |
|
JOHN BOOZMAN
|
senate |
Vanguard Scottsdale Fds Sht Trm Corp |
VSSPX |
FUND |
Sale
|
May 30, 2017 |
$$1,001-15,000 |
June 13, 2017 |
|
Sheldon Whitehouse
|
senate |
Victory Sycamore Established Value I |
VSEIX |
FUND |
Purchase
|
May 25, 2017 |
$$1,001 - $15,000 |
June 8, 2017 |
|
Susan M Collins
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Sale (Full)
|
May 24, 2017 |
$$15,001 - $50,000 |
June 6, 2017 |
|
Thomas J. Rooney
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
S
|
May 15, 2017 |
$$50,001 - $100,000 |
June 14, 2017 |
|
James B. Renacci
|
house |
CVS HEALTH CORPORATION (CVS) |
CVS |
STOCK |
Purchase
|
April 28, 2017 |
$$100,001 - $250,000 |
May 9, 2017 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
April 21, 2017 |
$$1,001 - $15,000 |
May 5, 2017 |
|
JOHN BOOZMAN
|
senate |
Vanguard Scottsdale Fds Sht Trm Corp |
VSSPX |
FUND |
Sales
|
April 10, 2017 |
$$1,001-15,000 |
May 12, 2017 |
|
Unknown
|
Unknown |
Versartis, Inc. (VSaR) |
VSAR |
STOCK |
Purchase
|
March 22, 2017 |
$$1,001 - $15,000 |
None |